Melanin-concentrating hormone functions in the nervous system: Food intake and stress

Expert Opinion on Therapeutic Targets

Volumn 7, Issue 4, 2003, Pages 495-511

  Hervieu, Guillaume ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

MSH; Antagonist; Anxiety; Depression; Diabetes; Energy regulation; Food intake; MCH receptors; Melanin concentrating hormone (MCH); Nervous system; Obesity; Stress

Indexed keywords

AMIDE; ANOREXIGENIC AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; APREPITANT; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; ENTEROSTATIN; GLUCAGON; INSULIN; LEPTIN; MELANIN CONCENTRATING HORMONE; MELANIN CONCENTRATING HORMONE RECEPTOR 1; MELANIN CONCENTRATING HORMONE RECEPTOR 1 ANTAGONIST; MELANIN CONCENTRATING HORMONE RECEPTOR 2; MELANOCORTIN; MONOAMINE OXIDASE INHIBITOR; N (6 DIMETHYLAMINOMETHYL 5,6,7,8 TETRAHYDRO 2 NAPHTHYL) 4' FLUORO 1,1' BIPHENYL 4 CARBOXAMIDE; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR AFFECTING AGENT; PHENTERMINE; PYRIMIDINE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; SNAP 7941; TETRAHYDROLIPSTATIN; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN; UNINDEXED DRUG;

ANOREXIA; ANXIETY DISORDER; BRAIN; CARDIOTOXICITY; DEPRESSION; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; ENERGY BALANCE; FEEDING DISORDER; FOOD INTAKE; HUMAN; MOOD DISORDER; NERVOUS SYSTEM FUNCTION; NONHUMAN; OBESITY; PERIPHERAL NERVOUS SYSTEM; PROTEIN ANALYSIS; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STRESS; TRANQUILIZING ACTIVITY;

AMINO ACID SEQUENCE; ANIMALS; APPETITE; BRAIN; CIRCADIAN RHYTHM; DOGS; EATING; EATING DISORDERS; ENERGY INTAKE; ENERGY METABOLISM; FERRETS; HUMANS; HYPOTHALAMIC HORMONES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MELANINS; MICE; MOLECULAR SEQUENCE DATA; PINEAL GLAND; PITUITARY HORMONES; PITUITARY-ADRENAL SYSTEM; PRIMATES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, PITUITARY HORMONE; STRESS;

EID: 0041828556     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.7.4.495     Document Type: Review

References (149)

1. FLEGAL KM, CARROLL MS, OGDEN CL, JOHNSON CL: Prevalence and trends in obesity among US adults, 1999-2000. JAMA (2002) 288:1723-1727.
2. DAS UN: Is obesity an inflammatory condition? Nutrition (2001) 17:953-966.
3. SAITO Y, NOTHACKER HP, CIVELLI O: Melanin-concentrating hormone receptor: an orphan receptor fits the key. Trends Endocrinol. Metab. (2000) 11(8):299-303.
4. HERVIEU GJ, MOULON L, CHAMBERS JK et al.: The melanin-concentrating hormone. In: Handbook of Chemical Neuroanatomy; Neuropeptide Receptors in the CNS. A Bjorklund, T Hokfelt, MJ Kuhar (Eds), Elsevier, Amsterdam (2003) 20:31-92.
5. HAYNES AC, STEVENS AJ, MUIR A et al.: A MCH receptor (SLC-1) antagonist reduces food intake and body weight in rats and mice. North American Association for the Study of Obesity, NAASO 2001. Obesity: from laboratory investigation to clinical practice. Annual Meeting of the NAASO, Quebec City, Canada, October 7 - 10 (2001). O152.
6. BOROWSKY B, DURKIN M, OGOZALER K et al.: Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat. Med. (2002) 8(8):825-830.
7. KAWAUCHI H, KAWAZOE I, TSUBOKAWA M, KISHIDA M, BAKER BI: Characterisation of MCH in chum salmon pituitaries. Nature (1983) 305:321-323.
8. BAKER BI: Melanin-concentrating hormone: a general vertebrate neuropeptide. Int. Rev. Cytol. (1991) 126:1-47.
9. BAKER BI: Melanin-concentrating hormone updated: functional considerations. Trends Endocrinol. Metab. (1994) 5(3):120-126.
10. NAHON JL: The melanin-concentrating hormone: from the peptide to the gene. Crit. Rev. Neurobiol. (1994) 8(4):221-262.
11. ZAMIR N, SKOTFISH G, BANSON ML, JACOBOWITZ DM: MCH: unique peptide neuronal system in the rat brain and pituitary gland. Proc. Natl. Acad. Sci. USA (1986) 83:1528-1531.
12. VAUGHAN JM, FISHER WH, HOEGER C, RIVIER J, VALE W: Characterisation of melanin-concentrating hormone from rat hypothalamus. Endocrinology (1989) 125:1660-1665.
13. BRETON C, FELLMAN D, BUGNON C: [Cloning and sequence analysis of cDNA of common precursors of three hypothalamic neuropeptides immunologically related to human somatocrinin 1-37, α-melanotropin and salmon melanin-concentrating hormone]. C.R. Acad. Sci. Paris (1989) 309:749-754. French.
14. NAHON JL, PRESSE F, BITTENCOURT JC, SAWCHENCKO P, VALE W: The rat melanin-concentrating hormone mRNA encodes multiple putative neuropeptides coexpressed in the dorsolateral hypothalamus. Endocrinology (1989) 125:2056-2065.
15. MAULON-FERAILLE L, DELLA-ZUANA O, SUPLY T et al.: Appetite-boosting property of pro-melanin-concentrating hormone(131-165) (neuropeptide-glutamic acid-isoleucine) is associated with proteolytic resistance. J. Pharmacol. Exp. Ther. (2002) 302(2):766-773.
16. EBERLE AN: The melanotropins - chemistry, physiology and mechanisms of action. Karger GmBH, Basel (1988).
17. TRITOS NA, MARATOS-FLIER E: Two important systems in energy homeostasis: melanocortins and MCH. Neuropeptides (1988) 33:339-349.
18. GRIFFOND B, BAKER BI: Cell and molecular cell biology of melanin-concentrating hormone. Int. Rev. Cytol. (2002) 213:233-277.
19. BITTENCOURT JC, PRESSE F, ARIAS C et al.: The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterisation. J. Comp. Neurol. (1992) 319:218-245.
20. DELECEA L, KILDUFF TS, PEYRONE C et al.: The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA (1998) 95:322-327.
21. SAKURAI T, AMEMIYA A, ISHII M et al.: Orexins and orexin receptors: a family of hypothalamic neuropeptides and G-protein-coupled receptors that regulate feeding behavior. Cell (1998) 92:573-585.
22. CLAPHAM JC, ARCH JRS, TADAYYON M: Anti-obesity drugs: a critical review of current therapies and future opportunities. Pharmacol. Ther. (2001) 89:81-121.
23. BERNADIS LL, BELLINGER LL: The lateral hypothalamic: area revisited: ingesting behavior. Neurosci. Behav. Rev. (1996) 20(2):189-287.
24. BRETON C, PRESSE F, HERVIEU G, NAHON JL: Structure and regulation of the mouse melanin-concenrating hormone mRNA and gene. Mol. Cell. Neurosci. (1993) 4:271-284.
25. HERVIEU G, SEGRETAIN D, NAHON JL: Developmental and stage-dependant expression of melanin-concentrating hormone in mammalian germ cells. Biol. Reprod. (1996) 54:1161-1171.
26. HERVIEU G, NAHON JL: Pro-melanin-concentrating hormone messenger ribonucleic acid and peptides expression in peripheral tissues of the rat. Neuroendocrinology (1995) 61:348-364.
27. HERVIEU G, VOLANT K, GRISHINA O, DESCROIX-VAGNE M, NAHON JL: Similarities in cellular expression and functions of melanin-concentrating hormone and atrial natriuretic factor in the rat digestive tract. Endocrinology (1996) 137(2):561-571.
28. VIALE A, ZHIZING Y, BRETON C et al.: The melanin-concentrating hormone gene in human: flanking region analysis, fine chromosome mapping, and tissue-specific expression. Mol. Brain Res. (1997) 46(1-2):243-255.
29. KNIGGE KM, WAGNER JE: Melanin-concentrating hormone involvement in PTZ-induced seizure in rat and guinea pig. Peptides (1997) 18(7):1095-1097.
30. MILLER CL, HRUBY VJ, MATSUNAGA TO, BICKFORD PC: α-MSH and MCH are functional antagonists in a CNS auditory gating paradigm. Peptides (1990) 14:431-440.
31. MACBRIDE RB, BECWITH E, SWENSON RR et al.: The actions of melanin-concentrating hormone on passive avoidance in rats: a preliminary study. Peptides (1994) 15(4):757-759.
32. GONZALEZ MI, VAZIRI S, WILSON CA: Behavioral effects of α-MSH and MCH after central administration in the female rat. Peptides (1996) 17(1):171-177.
33. MONZON ME, VARAS MM, DE BARIGLIO SR: Anxiogenesis induced by nitric oxide synthase inhibition and anxiolytic effect of melanin-concentrating hormone (MCH) in rat brain. Peptides (2001) 22(7):1043-1047.
34. JEZOVA D, BARTANUTZ V, WESTERGREN I et al.: Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: evidence for a site of action in brain regions protected by the blood-brain barrier. Endocrinology (1992) 130:1021-1029.
35. BLUET-PAJOT MT, PRESSE F, VOKO Z et al.: Neuropeptide E-I antagonises the action of melanin-concentrating hormone on stress-induced release of adrenocorticotropin in the rat. J. Neuroendocrinol. (1995) 7:297-303.
36. LUDWIG DS, MOUNTJOY KG, TATO JB et al.: Melanin-concentrating hormone: a functional antagonist in the hypothalamus. Am J. Physiol. (1998) 274:E627-E633.
37. ASHMEADE TE, JONES DNC, MUNTON RP et al.: An investigation into the effect of MCH on neuroendocrine markers in the rat. Eur. J. Neurosci. (2000) 12(Suppl. 11):217.2, 476.
38. GONZALEZ MI, BAKER BI, WILSON CA: Stimulatory effect of MCH on LH release. Neuroendocrinology (1997) 66:254-257.
39. VIALE A, KERDELHUE B, NAHON JL: 17 β-estradiol regulation of melanin concentrating hormone and neuropeptide-E-I contents in cynomolgus monkeys: a preliminary study. Peptides (1999) 20:553-559.
40. MURRAY JF, MERCER JG, ADAN RAH et al.: The effect of leptin on LH release is exerted in the zona incerta and mediated by MCH. J. Neuroendocrinol. (2000) 12:1133-1139.
41. TSUKAMURA H, THOMPSON RC, TSUKAHURA S et al.: Intracerebroventricular administration of melanin-concentrating hormone suppresses pulsatile luteinizing hormone release in the female rat. J. Neuroendocrinol. (2000) 12(6):529-534.
42. CHICCHIO SR, GALLARDO MGP, LOUZAN P, GUTNISKY V, TRAMEZZANI JH: Melanin-concentrating hormone stimulates the release of luteinizing hormone-releasing hormone and gonadotropins in the female rat acting at both median eminence and pituitary levels. Biol. Reprod. (2001) 64(5):1466-1472.
43. MONZON ME, DE SOUZA MM, IZQUIERDO LA, BARRO DM, DE BARIGLIO SR: MCH modifies memory retention in rats. Peptides (1999) 20:1517-1519.
44. VARAS M, PEREZ M, RAMIREZ O, DE BARIGLIO SR: Melanin concentrating hormone increase hippocampal synaptic transmission in the rat. Peptides (2002) 23(1):151-155.
45. HAWES BE, KIL E, GREEN B, O'NEILL K, FRIED S, GRAZIANO MP: The melanin-concentrating hormone receptor couples to multiple G proteins to activate diverse intracellular signaling pathways. Endocrinology (2000) 141(12):4524-4532.
46. BACHNER D, KREIENKRAMP HJ, RICHTER D: MIZIP, a highly conserved, vertebrate specific melanin-concentrating hormone receptor 1 interacting zinc-finger protein. FEBS Lett. (2002) 526(1-3):124-128.
47. GAO XB, VAN DEN POL AN: Melanin concentrating hormone depresses synaptic activity of glutamate and GABA neurons from rat lateral hypothalamus. J. Physiol. (Lond.) (2001) 533:237-252.
48. GAO XB, VAN DEN POL AN: Melanin-concentrating hormone depresses L-, N-, and P/Q-type voltage-dependent calcium channels in rat lateral hypothalamic neurons. J. Physiol. (Lond.) (2002) 542(1):273-286.
49. KOLAKOWSKI LF, JUNG BP, NGUYEN T et al.: Characterization of a human gene related to genes encoding somatostatin receptors. FEBS Lett. (1996) 398:253-258.
50. CHAMBERS J, AMES RS, BERGSMA D et al.: Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature (1999) 400:261-265.
51. SAITO Y, NOTHACKER HP, WANG ZW, LIN SHS, LESLIE F, CIVELLI O: Molecular characterization of the melanin-concentrating-hormone receptor. Nature (1999) 400:265-269.
52. BACHNER D, KREIENKRAMP H, WEISE C, BUCK F, RICHTER D: Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1). FEBS Lett. (1999) 457(3):522-524.
53. LEMBO PMC, GRAZZINI E, CAO J et al.: The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor. Nature Cell Biol. (1999) 1:267-271.
54. SHIMOMURA Y, MORI M, SUGO T et al.: Isolation and identification of melanin-concentrating hormone as the endogenous ligand of the SLC-1 receptor. Biochem. Biophys. Res. Commun. (1999) 261:622-626.
55. LAKAYE B, MINET A, ZORZI W, GRISAR T: Cloning of the rat brain cDNA encoding for the slc-1 G protein-coupled receptor reveals the presence of an intron in the gene. Biochim. Biophys. Acta Mol. Gell Res. (1998) 1401:216-220.
56. KOKKOTOU EG, TRITOS NA, MASTAITIS JW, SLIEKER L, MARATOS-FLIER E: Melanin-concentrating hormone receptor is a target of leptin action in the mouse brain. Endocrinology (2001) 142(2):680-686.
57. STADEL JM, WILSON S, BERGSMA DJ: Orphan G protein-coupled receptors: a neglected opportunity for pioneer drug discovery. Trends Pharmacol. Sci. (1997) 18:430-437.
58. MORI M, HARADA M, TERAO Y et al.: Cloning of a novel GPCR SLT, a subtype of the MCH receptor. Biochem. Biophys. Res. Commun. (2001) 283:1013-1018.
59. HILL J, DUCKWORTH M, MURDOCH P et al.: Molecular cloning and functional characterisation of MCH2, a novel human MCH receptor. J. Biol. Chem. (1997) 276(23,8):20125-20129.
60. SAILER AW, SANO H, ZENG Z et al.: Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R. Proc. Natl. Acad. Sci. USA (2001) 98:7564-7569.
61. AN S, CUTLER G, ZHAO JJ et al.: Identification and characterization of a melanin-concentrating hormone receptor. Proc. Natl. Acad. Sci. USA (2001) 98:7576-7581.
62. WANG S, BEHAN J, O'NEILL K et al.: Identification and pharmacological characterization of a novel human melanin-concentrating hormone receptor, MCH-R2. J. Biol. Chem. (2001) 276(37):34664-34670.
63. RODRIGUEZ M, BEAUVERGER P, NAINME I et al.: Cloning and molecular characterization of the novel human melanin-concentrating hormone receptor MCH2. Mol. Pharmacol. (2002) 60(4):632-639.
64. BOUTIN JA, SUPLY T, AUDINOT V et al.: Melanin-concentrating hormone and its receptors: state of the art. Can. J. Physiol. Pharmacol. (2002) 80(5):388-395.
65. AUDINOT V, LAHAYE C, SUPLY T et al.: SVK14 cells express an MCH blinding site different from the MCH1 or MCH2 receptor. Biochem. Biophys. Res. Commun. (2002) 295(4):841-848.
66. QU D, LUDWIG DS, GAMMELTOFT S et al.: A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature (1996) 380:243-244.
67. ROSSI M, BLOOM SR: MCH acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology (1997) 138(1):351-355.
68. EDWARDS CMB, ABUSNANA S, SUNTER D, MURPHY KG, GHATEI MA, BLOOM SR: The effect of the orexins on food intake: comparison with NPY, MCH and galanin. J. Endocrinol. (1999) 160:R7-R12.
69. DELLA-ZUANA O, PRESSE F, ORTOLA C, DUHAULT J, NAHON JL, LEVENS N: Acute and chronic administration of MCH enhances food intake and body weight in Wistar and Sprague-Dawley rats. Int. J. Obesity (2002) 26:1-7.
70. SHIMADA M, TRITOS NA, LOWELL BB, FLIER JS, MARATOS-FLIER E: Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature (1998) 396:670-674.
71. LUDWIG DS, TRITOS NA, MASTAITIS JW et al.: MCH overexpression in transgenic mice leads to obesity and insulin resistance. J. Clin. Invest. (2001) 107(3):379-386.
72. MARSH DJ, WEINGARTH DT, NOVI DE et al.: Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive and hyperphagic, and have altered metabolism. Proc. Natl. Acad. Sci. USA (2002) 99(5):3240-3245.
73. CHEN YY, HU CZ, HSU CK et al.: Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology (2002) 143(7):2469-2477.
74. YAMADA M, MIKAYAMA T, DUTTAROY A et al.: Mice lacking the M3 muscarinic receptor are hypophagic and lean. Nature (2001) 410:207-212.
75. PRESSE F, SOROKOVSKI I, MAX JP, NICOLAIDIS S, NAHON JL: MCH is a potent anorectic peptide regulated by food-deprivation and glucopenia in the rat. Neuroscience (1996) 71(3):735-745.
76. GRIFFOND B, DERAY A, NGUYEN NU, COLARD C, FELLMAN D: The synthesis of melanin-concentrating hormone is stimulated by ventromedial hypothalamic lesions in the rat lateral hypothalamus: a time-course study. Neuropeptides (1995) 28:267-275.
77. HENRY BA, TILBROOK AJ, DUNSHEA FR et al.: Long-term alterations in adiposity affect the expression of melanin-concentrating hormone and enkephalin but not proopiomelanocortin in the hypothalamus of ovariectomized ewes. Endocrinology (2000) 141(4):1506-1514.
78. MONDAL MS, NAKAZATO M, MATSUKARA S: Characterization of orexins (hypocretins) and melanin-concentrating hormone in genetically obese mice. Regul. Pept. (2002) 104:21-25.
79. MIZUNO TM, KLEOPOULOS SP, BERGEN HT, ROBERTS JL, PRIEST CA, MOBBS CV: Hypothalamic POMC mRNA is reduced by fasting in ob/ob and db/db mice, but is stimulated by leptin. Diabetes (1998) 47:294-297.
80. HUANG Q, VIALE A, PICARD F, NAHON JL, RICHARD D: Effects of leptin on MCH expression in the brain of lean and obese mice. Neuroendocrinology (1999) 69:145-153.
81. ROVERE C, VIALE A, NAHON JL, KITABGI P: Impaired processing of brain pro-neurotensin and pro-melanin-concentrating hormone in obese fat/fat mice. Endocrinology (1996) 137:2954-2958.
82. HANADA R, NAKAZATO M, MUTSUKURA S, MURAKAMI N, YOSHIMATI H, SAKATA T: Differential regulation of MCH and orexin genes in the AgRP/MC4 receptor system. Biochem. Biophys. Res. Commun. (2000) 268:88-91.
83. TRITOS NA, ELMQUIST JK, MASTAITIS, FLIER JS, MARATOS-FLIER E: Characterization of expression of hypothalamic appetite-regulating peptides in obese hyperleptinemic brown adipose tissue-deficient (uncoupling protein-promoter-driven diphteria toxin A) mice. Endocrinology (1998) 139:4634-4641.
84. SAHU A: Evidence suggesting that galanin, MCH, neurotensin, POMC and NPY are targets of leptin signalling in the hypothalamus. Endocrinology (1998) 139(2):795-798.
85. SAHU A: Interactions of neuropeptide Y, hypocretin-I (orexin A) and melanin-concentrating hormone on feeding in rats. Brain Res. (2002) 944(1-2):232-238.
86. STRICKER-KRONGRAD A, DIMITROV T, BECK B: Central and peripheral dysregulation of melanin-concentrating hormone in obese Zucker rats. Mol. Brain Res. (2001) 92(1-2):43-48.
87. SHIMOKAWA T, KUMA MV, LANE MD: Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides. Proc. Natl. Acad. Sci. USA (2002) 99(1):66-71.
88. VERLAETEN O, GRIFFOND B, KHUTH ST et al.: Downregulation of melanin concentrating hormone in virally-induced obesity. Mol. Cell. Endocrinol. (2001) 181(1-2):207-219.
89. ZHANG P, LIAND JD, SANDUSKY GE et al.: Hypothalamic MCH mRNA protein are increased in human obesity. Satellite Symposium; 9th International Congress of Obesity, France, Proceedings of the Symposium Int. J. Obesity (1999) P51.
90. SERGEYEV V, BROBERGER C, HOCKFELT T: Effect of LPS administration on the expression of POMC, NPY, galanin, CART and MCH mRNAs in the rat hypothalamus. Mol. Brain Res. (2001) 90:93-100.
91. MYSTKOWSKI P, SEELEY RJ, HAHN TM et al.: Hypothalamic MCH and estrogen-induced weight loss. J. Neurosci. (2000) 20(22):8637-8642.
92. ROSSI M, BEAK SA, CHOI S-J et al.: Investigation of the feeding effects of MCH on food intake - action independent of galanin and the melanocortin receptors. Brain Res. (1999) 846:164-170.
93. LOPEZ M, SEOANE LM, GARCIA MD, DIEGUEZ C, SENARIS R: Neuropeptide Y, but not agouti-related peptide or melanin-concentrating hormone, is a target peptide for orexin-A feeding actions in the rat hypothalamus. Neuroendocrinology (2002) 75(1):34-44.
94. CLEGG DJ, AIR EL, WOODS SC, SEELEY RJ: Eating elicited by orexin-A, but not melanin-concentrating hormone, is opioid mediated. Endocrinology (2002) 143(8):2995-3000.
95. KENNEDY AR, TODD JF, STANLEY SA et al.: Melanin-concentrating hormone (MCH) suppresses thyroid stimulating hormone (TSH) release, in vivo and in vitro, via the hypothalamus and the pituitary. Endocrinology (2001) 142(7):3265-3268.
96. TADAYYON M, WELTERS HJ, HAYNES AC, CLUDERAY JE, HERVIEU G: Expression of melanin-concentrating hormone receptors in insulin-producing cells: MCH stimulates insulin release in RINm5F and CRI-G1 cell-lines. Biochem. Biophys. Res. Commun. (2000) 275(2):709-712.
97. BUIJS RM, CHUN SJ, NIIJIMA A, ROMINJ HJ, NAGAI K: Parasympathetic and sympathetic control of the pancreas: a role for the suprachiasmatic nucleus and other hypothalamic centers that are involved in the regulation of food intake. J. Comp. Neurol. (2001) 431(4):405-423.
98. BRADLEY RL, KOKKOTOU EG, MARATOS-FLIER E, CHEATAM B: MCH regulates leptin synthesis and secrection in rat adipocytes. Diabetes (2000) 49:1073-1077.
99. BRADLEY RL, MANSFIELD JPR, MARATOS-FLIER E, CHEATAM B: Melanin-concentrating hormone activates signaling pathways in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. (2002) 283(3):E584-E592.
100. OLDFIELD BJ, GILES ME, WATSON A, ANDERSON C, COLVILL LM, MACKINLEY MJ: The neurochemical characterisation of hypothalamic pathways projecting polysynaptically to brown adipose tissue in the rat. Neuroscience (2002) 110(3):515-526.
101. SUPLY T, DELLA-ZUANA O, AUDINOT V et al.: SLC-1 receptor mediates effect of melanin-concentrating hormone on feeding behavior in rat: a structure-activity study. J. Pharmacol. Exp. Ther. (2001) 299(1):137-146.
102. MACDONALD D, MURGOLO N, ZHANG RM et al.: Molecular characterization of the melanin-concentrating hormone/receptor complex: identification of critical residues involved in binding and activation. Mol. Pharmacol. (2000) 58:217-225.
103. AUDINOT V, LAHAYE C, SUPLY T et al.: [I-125]-S36057: a new and highly potent radioligand for the melanin-concentrating hormone receptor. Br. J. Pharmacol. 133(3):371-378.
104. AUDINOT V, LAHAYE C, SUPLY T et al.: Structure-activity relationship studies of melanin-concentrating hormone (MCH)-related peptide ligands at SLC-1, the human MCH receptor. J. Biol. Chem. (2001) 276(17):13554-13562.
105. BEDNAREK MA, FEIGHNER SD, HRENIUK DL et al.: Short segment of human melanin-concentrating hormone that is sufficient for full activation of human melanin-concentrating hormone receptors 1 and 2. Biochemistry (2001) 40(31):9379-9386.
106. BEDNAREK MA, HRENIUK DL, TAN C et al.: Synthesis and biological evaluation in vitro of selective, high affinity peptide antagonists of human melanin-concentrating hormone action at human melanin-concentrating hormone receptor 1. Biochemistry (2002) 41(20):6383-6390.
107. BEDNAREK MA, TAN C, HRENIUK DL et al.: Synthesis and biological evaluation in vitro of a selective, high potency peptide agonist of human melanin-concentrating hormone action at human melanin-concentrating hormone receptor 1. J. Biol. Chem. (2002) 277(16):13821-13826.
108. TAKEKAWA S, ASAMI A, ISHIHARA Y et al.: T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist. Eur. J. Pharmacol. (2002) 438(3):129-135.
109. WITTY DR, HADLEY MS, HERVIEU GJ et al.: Biphenyl carboxamide antagonists of the human melanin-concentrating hormone receptor 11CBy (SLC-1); discovery and SAR. Medicinal Chemistry Symposium, Barcelona, Spain (2002).
110. HERVIEU GJ, CLUDERAY JE, HARRISON D et al.: The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, slc-1, in the central nervous system of the rat. Eur. J. Neurosci. (2000) 12:1194-1216.
111. SAITO Y, CHENG M, LESLIE FM, CIVELLI O: Expression of the melanin-concentrating-hormone receptor mRNA in the rat brain. J. Comp. Neurol. (2001) 435:26-42.
112. SAWCHENCKO PE: Toward a new neurobiology of energy balance, appetite and obesity. The anatomists weigh-in. J. Comp. Neurol. (1998) 402:435-441.
113. KILDUFF TS, DE LECEA L: Mapping of the mRNAs for the hypocretin/orexin and MCH receptors: network of overlapping peptide systems. J. Comp. Neurol. (2001) 435:1-5.
114. SCHWARTZ MW, GELLING RW: Rats lighten up with MCH antagonist. Nat. Med. (2002) 8(8):779-781.
115. BAKER BI, BIRD DJ, BUCKINGHAM JC: Salmonid melanin-concentrating hormone inhibits corticotropin release. J. Endocrinol. (1985) 106:R5-R8.
116. NAVARRA P, TSAGARAKIS S, COY DH, REES LH, BESSER GP, GROSSMAN AB: Rat melanin concentrating hormone does not modify the release of CRH-41 from rat hypothalamus or ACTH from the anterior pituitary in vitro. J. Endocrinol. (1990) 127:R1-R4.
117. PRESSE F, HERVIEU G, IMAKI T, SAWCHENKO PE, VALE W, NAHON JL: Rat melanin-concentrating hormone messenger ribonucleic acid expression: marked changes during development and after stress and glucocorticoid stimuli. Endocrinology (1992) 131:1241-1250.
118. PARKES DG, VALE W: Secretion of melanin-concentrating hormone and neuropeptide-EI from cultured rat hypothalamic cells. Endocrinology (1992) 131:1826-1831.
119. SANCHEZ M, BAKER BI, CELIS M: Melanin-concentrating hormone (MCH) antagonizes the effects of α-MSH and neuropeptide E-I on grooming and locomotor activities in the rat. Peptides (1997) 18:393-396.
120. GONZALEZ MI, KALIA V, HOLE DR, WILSON CA: α-MSH and MCH modify monoaminergic levels in the preoptic area of the rat. Peptides (1997) 18(3):387-392.
121. NAHON JL, PRESSE F, BRETON C, HERVIEU G, SCHORP M: Melanotropic peptides In: Structure and regulation of the melanin-concentrating hormone gene. Ann. NY Acad. Sci. (1993) 680:111-129.
122. NAHON JL, PRESSE F: Differential regulation of melanin-concentrating hormone gene expression in distinct hypothalamic areas under osmotic stimulation in rat. Neuroscience (1993) 55:709-720.
123. ABRAHAMSON EE, LEAK RK, MOORE RY: The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems. Neuroreport (2001) 12(2):435-440.
124. PARKES DG, RIVEST S, RIVIER C, SAWCHENKO PE, VALE W: MCH and NEI activate hypothalamic CRF neurons in conscious rats, Soc. Neurosci. San Diego (1992) 18 56.3:120.
125. KOOB GF: Corticotropin-releasing factor, norepinephrine, and stress. Biol. Psychiatry (1999) 46:1167-1180.
126. KRAMER MS, CUTLER N, FEIGHNER J et al.: Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science (1998) 281:1640-1645.
127. DALLMAN MF, AKANA SF, STRACK AM, HANSON ES, SEBASTIAN RJ: The neural network that regulates energy balance is responsive to glucocorticoids and insulin and also regulates HPA axis responsivity at a site proximal to CRF neurons. In: Stress: basic mechanisms and clinical implications. Ann. NY Acad. Sci. (1995) 711:730-742.
128. PEEKE PM, CHROUSOS GP: Hypercortisolism and obesity. In: Stress: basic mechanisms and clinical implications. Ann. NY Acad. Sci. (1995) 711:665-676.
129. ADAN RAH, GIPSEN WH: Brain melanocortin receptors: from cloning to function. Peptides (1997) 18(8):1279-1287.
130. SAPER CB, THOMAS C, CHOU TC, ELMQUIST JK: The need to feed: homeostatic and hedonic control of eating. Neuron (2002) 36:199-211.
131. KEMP EH, WATERMAN EA, HAWES BE et al.: The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo. J. Clin. Invest. (2002) 109(7):923-930.
132. HOCKFELT T: Neuropeptides in perspective: the last ten years. Neuron (1991)7:867-879.
133. HOCKFELT T, BROBERGER C, XU D Z-Q, SERGEYEV V, UBINK R, DIEZ M: Neuropeptides, an overview. Neuropharmacology (2000) 39:1337-1356.
134. TAN C, SANO H, IWAASA H et al.: Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression. Genomics (2002) 79:785-792.
135. VIALE A, ORTOLA C, RICHARD F et al.: Emergence of a brain-expressed variant melanin-concentrating hormone gene during higher primate evolution: a gene 'in search of a function'. Mol. Biol. Evol. (1998) 15:196-214.
136. VIALE A, COURSEAUX A, PRESSE F et al.: Structure and expression of the variant melanin-concentrating hormone genes: only PMCHL1 is transcribed in the developing human brain and encodes a putative protein. Mol. Biol. Evol. (1999) 17:1626-1640.
137. COURSEAUX A, NAHON JL: Birth of two chimeric genes in the Hominidae lineage. Science (2001) 2921:1293-1295.
138. MILLER CL, BURMEISTER M, THOMPSON RC: Antisense expression of the human prepro-MCH gene. Brain Res. (1998) 803:86-94.
139. BORSU L, PRESSE F, NAHON JL: The AROM gene, spliced mRNAs encoding new DNA/RNA-binding proteins are transcribed from the opposite strand of the MCH gene in mammals. J. Biol. Chem. (2000) 275(51):40576-40587.
140. TOUMANIANTZ G, BITTENCOURT JC, NAHON JL: The rat MCH gene encodes an additional protein in a different reading frame. Endocrinology (1996) 137(10):4518-4521.
141. TOUMANIANTZ GFERREIRA PC, ALLAEYS I, BITTENCOURT JC, NAHON JL: Differential neuronal expression and projections of MCH and MGOP in the rat brain. Eur. J. Neurosci. (2000) 12:4367-4380.
142. VERLAET M, ADAMANTIDIS A, COUMANS B et al.: Human immune cells express ppMCH mRNA and functional MCHR1 receptor. FERS Lett. (2002) 527(1-3):205-210.
143. HARRIS J, BIRD DJ: Supernatants from leucocytes treated with MCH and α-MSH have a stimulatory effect on rainbow trout phagocytes in vitro. Vet. Immunol. Immunopathol. (2000) 76:117-124.
144. CHAMORRO S, DELLA-ZUANA O, FAUCHERE JL et al.: Appetite suppression based on selective inhibition of NPY receptors. Int. J. Obesity (2002) 26(3):281-298.
145. CHECLER F, DAUCH P, BARELLI H, NAHON JL, VINCENT JP: Hydrolysis of rat melanin-concentrating hormone by endopeptidase 24.11 (neutral endopeptidase). Biochem. J. (1992) 286(1):217-221.
146. VIALE A, ORTOLA C, HERVIEU G et al.: Cellular localisation and role of prohormone convertases in the processing of pro-melanin concentrating hormone. J. Biol. Chem. (1999) 274(10):6536-6545.
147. KNIGGE KM, BAXTER-GRILLO D, SPECIALE J, WAGNER J: Melanotropic peptides in the mammalian brain: the melanin-concentrating hormone. Peptides (1996) 17(6):1063-1073.
148. KASTIN AJ, PAN WH, MANESS LM, BANKS WA: Peptides crossing the blood-brain barrier: some unusual observations. Brain Res. (1999) 848(1-2):96-100.
149. KASTIN AJ, AKERSTROM V, HACKLER L, ZADINA JE: [Phe(13),Tyr(19)]-melanin-concentrating hormone and the blood-brain barrier: role of protein binding. J. Neurochem. (2000) 74(1):385-391.